In March 2025, the company introduced new options for just a immediate-to-client presenting of its Wegovy weight loss drug. The company recognized a brand new pharmacy, known as NovoCare, which might cost buyers $499 per month for access to the drug, less than fifty percent the price of the drug through other pharmaceutical distribution networks.[5